Journal Mobile Options
Table of Contents
Vol. 89, No. 2, 2011
Issue release date: April 2011
Stereotact Funct Neurosurg 2011;89:89–95

Long-Term Surgical and Hardware-Related Complications of Deep Brain Stimulation

Doshi P.K.
In-charge Stereotactic and Functional Neurosurgical Program, Jaslok Hospital and Research Centre, Mumbai, India

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Objective: To evaluate the incidence of surgical and hardware-associated complications of deep brain stimulation (DBS) for a range of movement disorders. Methods: The study design is a retrospective analysis and review of surgical and hardware complications of DBS performed by a single surgeon from 1999 to 2009. A total of 153 cases of DBS (298 electrodes) for various movement disorders and a minimum follow-up of 1 year have been included. Two patients could not be implanted. A further 54 patients who underwent change of the implantable pulse generator (IPG) have been included for analysis of hardware-related complications. Results: The mean follow-up was 64 ± 36.15 (range = 12–129) months for the DBS group. Twenty-four (15.6%) patients developed complications. Confusion occurred in 3.9%, vasovagal attack in 1.9%, lead migration/misplaced lead in 2.5%, erosion and infection in 4.5% and IPG malfunction occurred in 1.4% of the patients. When calculated with respect to the number of electrodes and IPG replacements, the complication rate was lower (11.9%). Three patients had their system explanted, two of them being patients with dystonia who had inadvertently damaged their operative site. Conclusion: DBS surgery is a relatively safe surgery, with most of the complications being minor, without long-term morbidity. The complication rate in elderly (age ≧65 years) is comparable to that in younger patients. However, confusion is more frequent in this age group, and patients and relatives can be prepared to accept this as a transient morbidity.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Hariz MI: Complications of deep brain stimulation surgery. Mov Disord 2002;17(suppl 3):S162–S166.
  2. Beric A, Kelly PJ, Rezai A, Sterio D, Mogilner A, Zonenshayn M, Kopell B: Complications of deep brain stimulation surgery. Stereotact Funct Neurosurg 2001;77:73–78.
  3. Blomstedt P, Hariz MI: Hardware-related complications of deep brain stimulation: a ten year experience. Acta Neurochir (Wien) 2005;147:1061–1064; discussion 4.
  4. Joint C, Nandi D, Parkin S, Gregory R, Aziz T: Hardware-related problems of deep brain stimulation. Mov Disord2002;17(suppl 3): S175–S180.
  5. Kondziolka D, Whiting D, Germanwala A, Oh M: Hardware-related complications after placement of thalamic deep brain stimulator systems. Stereotact Funct Neurosurg 2002;79:228–233.
  6. Hu X, Jiang X, Zhou X, Liang J, Wang L, Cao Y, Liu J, Jin A, Yang P: Avoidance and management of surgical and hardware-related complications of deep brain stimulation. Stereotact Funct Neurosurg 2010;88:296–303.
  7. Chan DT, Zhu XL, Yeung JH, Mok VC, Wong E, Lau C, Wong R, Poon WS: Complications of deep brain stimulation: a collective review. Asian J Surg 2009;32:258–263.
  8. Da Costa A, Kirkorian G, Cucherat M, Delahaye F, Chevalier P, Cerisier A, Isaaz K, Touboul P: Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation 1998;97:1796–1801.
  9. Kenney C, Simpson R, Hunter C, Ondo W, Almaguer M, Davidson A, Jankovic J: Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. J Neurosurg 2007;106:621–625.
  10. Voges J, Waerzeggers Y, Maarouf M, Lehrke R, Koulousakis A, Lenartz D, Sturm V: Deep-brain stimulation: long-term analysis of complications caused by hardware and surgery – experiences from a single centre. J Neurol Neurosurg Psychiatry 2006;77:868–872.
  11. Umemura A, Jaggi JL, Hurtig HI, Siderowf AD, Colcher A, Stern MB, Baltuch GH: Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. J Neurosurg 2003;98:779–784.
  12. Limousin P, Speelman JD, Gielen F, Janssens M: Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatry 1999;66:289–296.
  13. Lyons KE, Wilkinson SB, Overman J, Pahwa R: Surgical and hardware complications of subthalamic stimulation: a series of 160 procedures. Neurology 2004;63:612–616.
  14. Seijo FJ, Alvarez-Vega MA, Gutierrez JC, Fdez-Glez F, Lozano B: Complications in subthalamic nucleus stimulation surgery for treatment of Parkinson’s disease: review of 272 procedures. Acta Neurochir (Wien) 2007;149:867–875; discussion 876.
  15. Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, Koudsie A, Limousin PD, Benazzouz A, LeBas JF, Benabid AL, Pollak P: Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 2003;349:1925–1934.
  16. Goodman RR, Kim B, McClelland S 3rd, Senatus PB, Winfield LM, Pullman SL, Yu Q, Ford B, McKhann GM 2nd: Operative techniques and morbidity with subthalamic nucleus deep brain stimulation in 100 consecutive patients with advanced Parkinson’s disease. J Neurol Neurosurg Psychiatry 2006;77:12–17.
  17. Kumar R, Lozano AM, Kim YJ, Hutchison WD, Sime E, Halket E, Lang AE: Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson’s disease. Neurology 1998;51:850–855.
  18. Tamma F, Rampini P, Egidi M, Caputo E, Locatelli M, Pesenti A, Chiesa V, Ardolino G, Foffani G, Meda B, Pellegrini M, Priori A: Deep brain stimulation for Parkinson’s disease: the experience of the Policlinico-San Paolo Group in Milan. Neurol Sci 2003;24(suppl 1):S41–S42.
  19. Levy RM, Lamb S, Adams JE: Treatment of chronic pain by deep brain stimulation: long term follow-up and review of the literature. Neurosurgery 1987;21:885–893.
  20. Benabid AL, Krack PP, Benazzouz A, Limousin P, Koudsie A, Pollak P: Deep brain stimulation of the subthalamic nucleus for Parkinson’s disease: methodologic aspects and clinical criteria. Neurology 2000;55(12 suppl 6): S40–S44.
  21. Deep-Brain Stimulation for Parkinson’s Disease Study Group: Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. N Engl J Med 2001;345:956–963.
  22. Hamani C, Richter E, Schwalb JM, Lozano AM: Bilateral subthalamic nucleus stimulation for Parkinson’s disease: a systematic review of the clinical literature. Neurosurgery 2005;56:1313–1321; discussion 21–24.
  23. Hariz MI, Fodstad H: Do microelectrode techniques increase accuracy or decrease risks in pallidotomy and deep brain stimulation? A critical review of the literature. Stereotact Funct Neurosurg 1999;72:157–169.
  24. Xiaowu H, Xiufeng J, Xiaoping Z, Bin H, Laixing W, Yiqun C, Jinchuan L, Aiguo J, Jianmin L: Risks of intracranial hemorrhage in patients with Parkinson’s disease receiving deep brain stimulation and ablation. Parkinsonism Relat Disord 2010;16:96–100.
  25. Oh MY, Abosch A, Kim SH, Lang AE, Lozano AM: Long-term hardware-related complications of deep brain stimulation. Neurosurgery 2002;50:1268–1274; discussion 74–76.
  26. Takubo H, Harada T, Hashimoto T, Inaba Y, Kanazawa I, Kuno S, Mizuno Y, Mizuta E, Murata M, Nagatsu T, Nakamura S, Yanagisawa N, Narabayashi H: A collaborative study on the malignant syndrome in Parkinson’s disease and related disorders. Parkinsonism Relat Disord 2003;9(suppl 1):S31–S41.
  27. Thomas A, Iacono D, Luciano AL, Armellino K, Onofrj M: Acute akinesia or akinetic crisis in Parkinson’s disease. Neurol Sci 2003;24:219–220.
  28. Derost PP, Ouchchane L, Morand D, Ulla M, Llorca PM, Barget M, Debilly B, Lemaire JJ, Durif F: Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population? Neurology 2007;68:1345–1355.
  29. Vesper J, Haak S, Ostertag C, Nikkhah G: Subthalamic nucleus deep brain stimulation in elderly patients – analysis of outcome and complications. BMC Neurol 2007;7:7.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50